Should you buy National Australia Bank Ltd?

Despite a big dividend, it might not be the right time to get on board with our top business bank.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Compared to its big bank peers, shares in National Australia Bank Ltd. (ASX: NAB) seem to offer a lot more, but continue to deliver underperformance. What's more they are seemingly cheaper across a number of conventional valuation metrics. So far in 2014 the stock price has fallen 6% while the S&P/ASX 200 Index (ASX: XJO) (INDEX: ^AXJO) is up around 1%.

So could now be the opportunity you've been waiting for, or is this turnaround story never going to turn? I'd like to think it's the latter but history tells us it's not.

However, according to Morningstar's analysts' consensus, NAB is expected to pay a 6.1% fully franked dividend in the coming year which could prove too irresistible for self-managed superannuation funds and those seeking income from dividends. I couldn't blame them either because that's a dividend yield of around 8.8% grossed-up!

NAB's share price woes can be put down to a number of alarming trends including its profitability in the local market and its difficulty paying off a large commercial property portfolio in the UK. However with property prices increasing and the UK economy on the mend, both the Clydesdale Bank and Yorkshire Bank can be expected to lift cash earnings in FY14.

In New Zealand, NAB continues to maintain good profitability with a net interest margin of 2.34% however, given the recent rises in property prices (among other things), there is unlikely to be significant growth stemming from its NZ operations.

In the Australian Banking division (where NAB holds around 21.6% market share of business banking and over 30% of agribusiness) profitability continues to slip. Whilst business lending remains lucrative, NAB's aggressive push into Australian housing has come at the expense of its net interest margin which, in the first half of FY14, was 1.36%.

To buy, or not?

NAB could be the dark horse of the banks in FY14 but given its current valuation I feel it's still not a bargain. Australia and New Zealand Banking Group (ASX: ANZ) and Macquarie Group Ltd (ASX: MQG) seem to have a better upside at current prices.

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »